Inflammation modulates human HDL composition and function in vivo
Atherosclerosis, 05/25/2012
De la Llera Moya M et al. – The data support the concept that “atherogenic–HDL dysfunction” and impaired reverse cholesterol transport (RCT) occur in human inflammatory syndromes, largely independent of changes in plasma HDL–C and ApoA–I levels.



